Cell Biochemistry and Biophysics

, Volume 60, Issue 3, pp 225–229

Effect of Zymosan on Antioxidant and Immune Function of S180 Tumor-Bearing Mice

  • Xiao-li Liu
  • Ning Lin
  • Deng Zan
  • Jing-Jue Yuan
  • Dong-Lian Cai
Original Paper


The objective is to study the effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice. Seventy Kunming mice were randomly divided into seven groups: a normal control group (NC), a tumor control group (TC), three dose groups of zymosan (low, medium, high), a cyclophosphamide (Cy) group, and a combination of zymosan and Cy group. The S180 tumor-bearing mice model was established by the inoculation of cancer cell suspension subcutaneously in the mouse’s right anterior limb. At the 19th day, malondialdehyde (MDA), glutathione peroxidase (GSH-Px), and superoxide dismutase (SOD) activity in liver homogenate were analyzed. The reverse transcriptase-polymerase chain reaction was used to determine the mRNA expression levels of IL-2, TNF-α, and TGF-β1. The activity of GSH-Px and SOD in the liver increased with the dose of zymosan, whereas the activity of MDA significantly decreased in the higher-dose groups of zymosan, compared to the TC group (P < 0.01). In the zymosan groups, mRNA expression levels in tissues of S180 tumor-bearing mice were significantly higher for TNF-α and IL-2, but lower for TGFβ1 than in the Cy or TC group (P < 0.01). The high-dose of zymosan markedly showed a depressant effect on S180 tumor, enhanced by the action of Cy that increased mRNA expression levels of TNF-α and IL-2. The mechanism of zymosan on the inhibition of tumor growth may be due to its ability to enhance the antioxidant and immune function in a dose-dependent manner.


Zymosan Tumor Antioxidant Immunity 





Glutathione peroxidase










Normal control


Reverse transcriptase-polymerase chain reaction


Standard deviation


Superoxide dismutase


Tumor control


  1. 1.
    Wasowicz, W., Reszka, E., Gromadzinska, J., & Rydzynski, K. (2003). The role of essential elements in oxidative stress. Comments on Toxicology, 9, 39–48.CrossRefGoogle Scholar
  2. 2.
    Mates, J. M., Perez-Gomez, C., & Nunez dC, I. (1999). Antioxidant enzymes and human diseases. Clinical Biochemistry, 32, 595–603.PubMedCrossRefGoogle Scholar
  3. 3.
    Gracy, R. W., Talent, J. M., Kong, Y., & Conrad, C. C. (1999). Reactive oxygen species: The unavoidable environmental insult? Mutation Research, 428, 17–22.PubMedGoogle Scholar
  4. 4.
    Woutersen, R.A. & Appel, M.J. (1998). Food and chemical toxicology. Symposium on antioxidants and health Bordeaux, France (pp. 981–984).Google Scholar
  5. 5.
    Estrada, A., Yun, C. H., Van Kessel, A., Li, B., Hauta, S., & Laarveld, B. (1997). Immunomodulatory activities of oat beta-glucan in vitro and in vivo. Microbiology and Immunology, 41, 991–998.PubMedGoogle Scholar
  6. 6.
    Li, F., & Li, Y. (1998). Effect of polysaccharides of brewers yeast on the immune cells in mice. Journal of Norman Bethune University of Medicine and Science, 24, 124–126.Google Scholar
  7. 7.
    Zhang, J., Liu, J., & Dang, X. (2000). Effect of yeast competence products and zymosan A on erythrocyte immune adherence. Journal of Xi’an Medical University, 21, 18–19.Google Scholar
  8. 8.
    Xu, J., Hou, G., Huang, D., & Lu, S. (2002). Effects of zymosan on the production of nitric oxide and interleukin-1 in mouse peritoneal macrophages. Chinese Journal of Biochemical Pharmaceuticals, 23, 67–68.Google Scholar
  9. 9.
    Williams, N. (1996). Tumor cells fight back to beat immune system. Science. 274, 1302.Google Scholar
  10. 10.
    Li, X., Liu, F., & Zhang, H. (2006). Effect of Traditional Chinese medicine FGC-6 on tumor inhibition and immune regulation on H22 tumor bearing mice. Chinese Journal of Gerontology, 6, 92–93.Google Scholar
  11. 11.
    Bosscher, D., Breynaert, A., Pieters, L., & Hermans, N. (2009). Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. Journal of Physiology and Pharmacology, 60(6), 5–11.PubMedGoogle Scholar
  12. 12.
    Troy, E. B., & Kasper, D. L. (2010). Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Frontiers in Bioscience, 15, 25–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Kimura, K., Bowen, C., Spiegel, S., & Gelmann, E. P. (1999). Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis. Cancer Research, 59, 1606–1614.PubMedGoogle Scholar
  14. 14.
    Capelli, E., Barni, S., Vaccarone, R., Fortis, C., & Nano, R. (1996). Cell activation and death (apoptosis) induced by IL-2: Ultrastructural evidence. Anticancer Research, 16, 1775–1780.PubMedGoogle Scholar
  15. 15.
    Zhou, Z., Wu, X., & Zhu, Y. (2003). Clinical significance of measured expression level of cytokine in peripheral blood cells from patients with malignant carcinoma. Henan Journal of Oncology, 16, 159.Google Scholar
  16. 16.
    Schuster, N., & Krieglstein, K. (2002). Mechanisms of TGF-beta-mediated apoptosis. Cell and Tissue Research, 307, 1–14.PubMedCrossRefGoogle Scholar
  17. 17.
    Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., & Weinberg, R. A. (2001). TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nature Cell Biology, 3, 708–714.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Xiao-li Liu
    • 1
  • Ning Lin
    • 1
    • 2
  • Deng Zan
    • 1
  • Jing-Jue Yuan
    • 1
  • Dong-Lian Cai
    • 1
  1. 1.Department of Clinical Nutrition, Changhai HospitalThe First Affiliated Hospital of The Second Military Medical UniversityShanghaiChina
  2. 2.Department of Clinical NutritionThe Military General Hospital of Chengdu PLAChengduChina

Personalised recommendations